Jaguar Animal Health, Inc. (NASDAQ:JAGX) saw a large growth in short interest in August. As of August 15th, there was short interest totalling 2,176,922 shares, a growth of 46.6% from the July 31st total of 1,484,579 shares. Based on an average trading volume of 474,227 shares, the days-to-cover ratio is presently 4.6 days.

JAGX has been the subject of several analyst reports. HC Wainwright set a $2.00 target price on shares of Jaguar Animal Health and gave the stock a “buy” rating in a report on Tuesday, July 11th. Rodman & Renshaw initiated coverage on shares of Jaguar Animal Health in a report on Tuesday, July 11th. They issued a “buy” rating and a $2.00 target price for the company.

Shares of Jaguar Animal Health (NASDAQ:JAGX) opened at 0.397 on Friday. Jaguar Animal Health has a 12-month low of $0.34 and a 12-month high of $1.53. The company has a 50-day moving average of $0.53 and a 200 day moving average of $0.75. The stock’s market capitalization is $42.96 million.

COPYRIGHT VIOLATION NOTICE: “Jaguar Animal Health, Inc. (JAGX) Sees Significant Increase in Short Interest” was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece of content on another publication, it was stolen and reposted in violation of United States and international trademark & copyright laws. The correct version of this piece of content can be read at

About Jaguar Animal Health

Jaguar Health, Inc, formerly Jaguar Animal Health, Inc, is a natural-products pharmaceuticals company. The Company is focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and animals on a global basis. The Company, through its subsidiary Napo Pharmaceuticals, Inc, is focused on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas.

Receive News & Stock Ratings for Jaguar Animal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Animal Health Inc. and related stocks with our FREE daily email newsletter.